NYSE ARCA | ETF
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 6.12% |
| CELC | Celcuity LLC | Healthcare | Biotechnology | 5.86% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 5.66% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 5.36% |
| BAYN | Bayer AG NA | Healthcare | Drug Manufacturers - General | 4.67% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 4.66% |
| GMAB | Genmab A/S | Healthcare | Biotechnology | 4.25% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 4.23% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 4.21% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.20% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.18% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 4.04% |
| 6160 | BeOne Medicines AG | Healthcare | Biotechnology | 4.04% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.99% |
| 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 3.87% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.87% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.76% |
| ROP | Roche Holding AG | Healthcare | Drug Manufacturers - General | 3.74% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.61% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 3.60% |